Advances with microRNAs in Parkinson's disease research

L Ma, L Wei, F Wu, Z Hu, Z Liu… - Drug design, development …, 2013 - Taylor & Francis
Parkinson's disease (PD) is the second-most common age-dependent neurodegenerative
disorder and is caused by severe degeneration of dopaminergic neurons in the substantia …
被引用次数：75 相关文章

Advances with microRNAs in Parkinson's disease research

L Ma, L Wei, F Wu, Z Hu, Z Liu, W Yuan - Drug Design, Development …, 2013 - go.gale.com
Parkinson's disease (PD) is the second-most common age-dependent neurodegenerative
disorder and is caused by severe degeneration of dopaminergic neurons in the substantia …

Advances with microRNAs in Parkinson's disease research

L Ma, L Wei, F Wu, Z Hu, Z Liu… - Drug Design …, 2013 - search.proquest.com
Parkinson's disease (PD) is the second-most common age-dependent neurodegenerative
disorder and is caused by severe degeneration of dopaminergic neurons in the substantia …
[PDF] semanticscholar.org

[PDF][PDF] Advances with microRNAs in Parkinson's disease research

L Ma - Drug Design, Development and Therapy, 2013 - pdfs.semanticscholar.org
Parkinson's disease (PD) is the second-most common age-dependent neurodegenerative
disorder and is caused by severe degeneration of dopaminergic neurons in the substantia …

Advances with microRNAs in Parkinson's disease research

L Ma, L Wei, F Wu, Z Hu, Z Liu… - Drug Design, Development …, 2013 - dovepress.com
Parkinson's disease (PD) is the second-most common age-dependent neurodegenerative
disorder and is caused by severe degeneration of dopaminergic neurons in the substantia …
[HTML] europepmc.org

[HTML][HTML] Advances with microRNAs in Parkinson's disease research.

L Ma, L Wei, F Wu, Z Hu, Z Liu… - Drug Design, Development …, 2013 - europepmc.org
Parkinson's disease (PD) is the second-most common age-dependent neurodegenerative
disorder and is caused by severe degeneration of dopaminergic neurons in the substantia …
[PDF] scienceopen.com

[PDF][PDF] Advances with microRNAs in Parkinson's disease research

L Ma - Drug Design, Development and Therapy, 2013 - scienceopen.com
Parkinson's disease (PD) is the second-most common age-dependent neurodegenerative
disorder and is caused by severe degeneration of dopaminergic neurons in the substantia …
[PDF] psu.edu

[PDF][PDF] Advances with microRNAs in Parkinson's disease research

L Ma - Drug Design, Development and Therapy, 2013 - Citeseer
Parkinson's disease (PD) is the second-most common age-dependent neurodegenerative
disorder and is caused by severe degeneration of dopaminergic neurons in the substantia …

Advances with microRNAs in Parkinson's disease research

L Ma, L Wei, F Wu, Z Hu, Z Liu… - Drug design …, 2013 - pubmed.ncbi.nlm.nih.gov
Parkinson's disease (PD) is the second-most common age-dependent neurodegenerative
disorder and is caused by severe degeneration of dopaminergic neurons in the substantia …
[HTML] nih.gov

[HTML][HTML] Advances with microRNAs in Parkinson's disease research

L Ma, L Wei, F Wu, Z Hu, Z Liu… - Drug Design, Development …, 2013 - ncbi.nlm.nih.gov
Parkinson's disease (PD) is the second-most common age-dependent neurodegenerative
disorder and is caused by severe degeneration of dopaminergic neurons in the substantia …